In November, virologist Beata Halassy announced to the world that she had cured her own breast cancer using a treatment ...

Indian doctor Shikhar Ganjoo criticized Bryan Johnson's commitment to anti-aging science after Johnson left Nikhil Kamath’s ...

Amid the federal funding uncertainty for health and sciences, local life science leaders say this could be a moment for industry partners, investors and others to step up and support the sector.

Biotech entrepreneur Bryan Johnson prematurely ended his podcast with Nikhil Kamath due to poor air quality in the recording ...

NPR's A Martinez speaks with tech entrepreneur Bryan Johnson about the Netflix documentary "Don't Die: The Man That Wants To Live Forever," which portrays his quest to slow aging.

A tech millionaire famed for undertaking wild experiments in a bid to “not die” has published “intimate” details about his son. Bryan Johnson has amassed a huge following after he sold his ...

Another of those "heavy hitters" was Brian Johnson, the offensive coordinator the Eagles fired at the end of last season. Quinn had been following Johnson's path since the latter's days as the ...

Analysts cite Stelara exclusivity loss and MedTech competition as key challenges for Johnson & Johnson. Price target revisions: Tim Anderson lowers J&J forecast from $160 to $159. The ...

In this article, we are going to take a look at where Johnson & Johnson (NYSE ... weak or that they won't rebound in the future. Alex Bryan, Morningstar's director of product management for ...

Biotech and pharma dealmaking is off to a good start in 2025. Meanwhile, digital health fundraising defined by “David and Goliath dynamic” in 2024, report says.

Bryan Johnson, a tech entrepreneur, has stopped using rapamycin, a drug not approved for anti-aging by the FDA, following concerns it may have aged him and caused infections. Johnson experienced ...